Bank Of America Corp Caladrius Biosciences, Inc. Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.63 - $1.03 $44 - $73	-71 Reduced 12.39%	502 $0
Q4 2021 Feb 08, 2022	SELL	$0.83 - $1.22 $190 - $279	-229 Reduced 28.55%	573 $0
Q3 2021 Nov 15, 2021	SELL	$1.15 - $1.57 $525 - $717	-457 Reduced 36.3%	802 $0
Q2 2021 Sep 13, 2021	BUY	$1.4 - $1.9 $1,762 - $2,392	1,259 New	1,259 $3,000

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.